$IBO has presented a rather magnificent momentum in the market and is moving up with a firm footing. Shares are trading at $0.05 per share with no noted loss percentage
The company’s largest share bearer Cantone Asset Management and its affiliates have tendered 100 Million shares in a takeover bid from Viston Swiss United.
Petroteq, an environment friendly oil extraction and sand remediation corporation, offers an average trading volume of 1,776,722 units for daily trade and investor related activities.
Petroteq Energy Inc. is highly engaged in fostering oil sands and expanding production capacity. It is especially focused on its proprietary technologies for environmentally protected oil extraction, particularly heavy oil from oil sands, shale stores, and shallow oil deposits.
The TSX venture exchange has accepted the long awaited application of $PQEFF for resumption of trading in its common shares on the market, the investors would now be allowed to trade the shares on the TSX-V by the end of this week.
Adrian Patasar, the CEO, has negotiated the terms to secure a majority stake in Baller Mixed Reality, a start-up venture involved in developing Autographed Metaverse Collectibles as 3D-AR NFTs endorsed by compelling, incredible athletes and entertainers.
Petroteq Energy Inc is a Canadian-incorporated holding company. The trading continues on the OTC market and currently sits at $0.3033 with a little upside in the previous closure, currently having a volume of 249K+ since the opening.
In a recent tweet $AMLH mentioned plans of meeting different organizations and also celebrity athletes to take its NFT venture to new horizons for fruitful business development
The perpetual lawsuit held between hemostenix and aspire health science has met its end, eventually enabling the company to gain back ultimate possession over its lost intellectual property.
Hemostemix has announced that it has closed the previously released non-brokered convertible debenture in accordance with offering $1,000 principal amount of each debenture.
As the court ruled in the favor of Hemostemix and all the intellectual property relating to ACP-01 was returned to Hemostemix, the management is independent to cultivate important business development strategies as well as it enables the extraction of phase 2 clinical trial data.
For settling all the financial transactions of the company, Hemostemix has appointed a special advisor, Mr. Richard Groome, to the CEO, who believes that he’s a great addition to the team.
Hemostemix (TSXV: $HEM) primarily deals with developing and commercializing innovative blood-derived stem cell therapies. Is now entered into an agreement with Aspire and has agreed to settle the dispute of data stealth and intellectual property infringement regarding ACP-01.
In connection with the previous agreement dispute, Hemostemix has recently announced the closure of the agreement and the settlement of all prosecution with Aspire Health Science in a very recent news release by the company itself.
In the very latest press release of the company, it has announced the partnership of Baller Mixed Reality, an American leisure holding company, with Echelon Culture, a strategic marketing agency.
